Cantor Fitzgerald Reiterates Overweight on Aziyo Biologics, Maintains $8 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Brandon Folkes has reiterated an Overweight rating on Aziyo Biologics (NASDAQ:AZYO) and maintained a price target of $8.
August 15, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst has reiterated an Overweight rating on Aziyo Biologics and maintained a price target of $8.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Aziyo Biologics. The maintained price target of $8 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100